Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gene-Siew Ngian

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Arthritis Care & Research|April 13, 2026
Characteristics and outcomes of male participants in the Australian Scleroderma Cohort Study (ASCS)Emily Lin, Dylan Hansen, Laura Ross, et al.
Clinical and Experimental Rheumatology|April 7, 2016
Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort StudyClaire Owen, Gene-Siew Ngian, Kathleen Elford, et al.
Rheumatology (Oxford, England)|September 10, 2020
Occupational silica exposure in an Australian systemic sclerosis cohortShreeya Patel, Kathleen Morrisroe, Susanna Proudman, et al.
Clinical and Experimental Rheumatology|October 3, 2018
The role of inflammatory markers in assessment of disease activity in systemic sclerosisLaura Ross, Wendy Stevens, Candice Rabusa, et al.
Arthritis Care & Research|September 4, 2024
Comparison of Three Physician Global Assessment Instruments in Systemic SclerosisLaura Ross, Dylan Hansen, Susanna Proudman, et al.
Seminars in Arthritis and Rheumatism|April 17, 2024
Prognostic and functional importance of both overt and subclinical left ventricular systolic dysfunction in systemic sclerosisJessica L Fairley, Dylan Hansen, Susanna Proudman, et al.
Canadian Respiratory Journal|November 12, 2025
Impact of Comorbidities on Treatments and Outcomes of Systemic Sclerosis-Associated Pulmonary Arterial HypertensionLisa Lim, Dylan Hansen, Jessica Fairley, et al.
Arthritis Research & Therapy|May 12, 2023
Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosisJessica L Fairley, Dylan Hansen, Laura Ross, et al.
Arthritis Care & Research|September 9, 2024
Prevalence and Outcomes of Gastrointestinal Manifestations in an Australian Scleroderma CohortAlannah Quinlivan, Dylan Hansen, Wendy Stevens, et al.
Arthritis Care & Research|March 25, 2024
Evaluation of the European Society of Cardiology Risk Assessment Score in Incident Systemic Sclerosis-Associated Pulmonary Arterial HypertensionZoe Brown, Dylan Hansen, Wendy Stevens, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Arthritis Care & Research|April 13, 2026
Characteristics and outcomes of male participants in the Australian Scleroderma Cohort Study (ASCS)Emily Lin, Dylan Hansen, Laura Ross, et al.
Clinical and Experimental Rheumatology|April 7, 2016
Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort StudyClaire Owen, Gene-Siew Ngian, Kathleen Elford, et al.
Rheumatology (Oxford, England)|September 10, 2020
Occupational silica exposure in an Australian systemic sclerosis cohortShreeya Patel, Kathleen Morrisroe, Susanna Proudman, et al.
Clinical and Experimental Rheumatology|October 3, 2018
The role of inflammatory markers in assessment of disease activity in systemic sclerosisLaura Ross, Wendy Stevens, Candice Rabusa, et al.
Arthritis Care & Research|September 4, 2024
Comparison of Three Physician Global Assessment Instruments in Systemic SclerosisLaura Ross, Dylan Hansen, Susanna Proudman, et al.
Seminars in Arthritis and Rheumatism|April 17, 2024
Prognostic and functional importance of both overt and subclinical left ventricular systolic dysfunction in systemic sclerosisJessica L Fairley, Dylan Hansen, Susanna Proudman, et al.
Canadian Respiratory Journal|November 12, 2025
Impact of Comorbidities on Treatments and Outcomes of Systemic Sclerosis-Associated Pulmonary Arterial HypertensionLisa Lim, Dylan Hansen, Jessica Fairley, et al.
Arthritis Research & Therapy|May 12, 2023
Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosisJessica L Fairley, Dylan Hansen, Laura Ross, et al.
Arthritis Care & Research|September 9, 2024
Prevalence and Outcomes of Gastrointestinal Manifestations in an Australian Scleroderma CohortAlannah Quinlivan, Dylan Hansen, Wendy Stevens, et al.
Arthritis Care & Research|March 25, 2024
Evaluation of the European Society of Cardiology Risk Assessment Score in Incident Systemic Sclerosis-Associated Pulmonary Arterial HypertensionZoe Brown, Dylan Hansen, Wendy Stevens, et al.
Pageof 7